A treatable muscle disease.
Burke
Georgina
G
Department of Neurology, Wessex Neurological Centre, Southampton General Hospital, Southampton SO16 6YD, UK. Georgina.Burke@suht.swest.nhs.uk
Allen
David
D
Arunachalam
Ramamurthy
R
Beeson
David
D
Hammans
Simon
S
D017677:Age Distribution; D000368:Aged; D018450:Disease Progression; D004809:Ephedrine / Q000494:pharmacology / Q000627:therapeutic use; D005121:Extremities / Q000503:physiopathology; D005260:Female; D020233:Gait Disorders, Neurologic / Q000209:etiology / Q000503:physiopathology* / Q000628:therapy*; D020022:Genetic Predisposition to Disease; D006732:Horner Syndrome / Q000235:genetics; D006801:Humans; D009124:Muscle Proteins / Q000235:genetics; D018908:Muscle Weakness / Q000209:etiology / Q000503:physiopathology* / Q000628:therapy*; D018482:Muscle, Skeletal / Q000503:physiopathology; D009135:Muscular Diseases / Q000235:genetics / Q000503:physiopathology* / Q000628:therapy*; D020294:Myasthenic Syndromes, Congenital / Q000175:diagnosis / Q000503:physiopathology* / Q000628:therapy*; D009469:Neuromuscular Junction / Q000235:genetics
C511692:DOK7 protein, human; D009124:Muscle Proteins; D004809:Ephedrine